JAX-NYSCF collaborates with GSK to advance human cellular models of neurodegenerative disease
GSK
Jackson Laboratory Feb 17 2026 The Jackson Laboratory–New York Stem Cell Foundation Collaborative (JAX-NYSCF) today announced a five-year strategic research collaboration with GSK focused on advancing human cellular models of neurodegenerative disease, including Alzheimer's disease. The collaboration reflects a strategic focus that brings together human stem cell research, advanced data science tools, and large-scale research systems to help close a long-standing gap between scientific
din zilele anterioare